Erythema nodosum secondary to granulocyte colony-stimulating factor in a patient with Hodgkin lymphoma during CD34+ cell mobilization for autologous peripheral blood stem cell transplantation: a dose-mediated effect

Biol Blood Marrow Transplant. 2005 Oct;11(10):816-7. doi: 10.1016/j.bbmt.2005.07.003.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Erythema Nodosum / chemically induced*
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Hematopoietic Stem Cell Mobilization / adverse effects*
  • Hematopoietic Stem Cell Mobilization / methods
  • Hodgkin Disease / complications*
  • Hodgkin Disease / therapy
  • Humans
  • Male
  • Peripheral Blood Stem Cell Transplantation / adverse effects
  • Peripheral Blood Stem Cell Transplantation / methods
  • Transplantation, Autologous

Substances

  • Granulocyte Colony-Stimulating Factor